Fig. 2From: Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisoneKaplan-Meier survival curves of PFS and OS stratified by PSA at corticosteroid switch (A: PFS; B: OS), mCRPC-free survival (C: PFS; D: OS). mCRPC: metastatic castration-resistant prostate cancer; PFS: progression-free survival; OS: overall survivalBack to article page